LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.

Biotechnology

LyGenesis

Michael Hufford

Jacqueline Jeha, MPH

Paulo Fontes, MD, FACS

Jennifer Taylor

Eric Lagasse

Paulo A Fontes

LyGenesis' CEO and Executive Team includes Paulo A Fontes and 2 others.

CEO and Executive Team

Leadership Team

CEO and Executive Team

About

Team members

Other teams at LyGenesis

Leadership Team